Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemptown is a cannabinoid-focused life sciences company specializing in the cultivation, extraction, and commercialization of rare cannabinoids, most notably Cannabigerol (CBG). Based in Oregon, the company operates large-scale hemp acreage and utilizes proprietary genetics to produce high-yield CBG crops. Their product portfolio includes a range of consumer wellness products such as tinctures, topicals, and functional beverages. Hemptown's vertically integrated model allows them to control the supply chain from seed to finished product, targeting therapeutic areas like pain management and sleep. The company also provides wholesale raw materials, including crude oil, distillate, and isolate, to other manufacturers in the hemp industry. By focusing on minor cannabinoids, Hemptown aims to differentiate itself in the crowded CBD market through science-backed formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemptown.